Literature DB >> 9569907

[Repeated thyroid surgery. Indications and results].

F Menegaux1, L Leenhardt, M Dahman, G Schmitt, A Aurengo, J P Chigot.   

Abstract

OBJECTIVES: To analyze the histology results and to assess operative risk of iterative operations for thyroid surgery. PATIENTS AND METHODS: A total of 249 re-operations were performed in 248 patients over a 6.5 year period. Two groups of patients were defined according to the indications for re-operation. Group 1: 80 patients; pathology examination of the surgical specimen discovered thyroid cancer. Group 2: 169 patients; recurrent nodular goitre after an initially benign disease.
RESULTS: In group 1, 14 cancers were bilateral (17.5%) and 7 patients had cervical node metastases (8.8%). In group 2, 19 cancers were discovered (11.1%), including 5 cases with cervical node invasion (26.3%) and 4 with visceral metastases (21.1%). Twenty complications occurred in 20 patients (8%): compressive cervical hematomas (n = 3, 1.2%), recurrent nerve palsy (n = 7, 2.8%), hypoparathyroidism (n = 9, 3.6%; including 3 definitive cases, 1.2%) and mediastinitis (n = 1). These complications were significantly more frequent in patients re-operated for hyperthyroidism or those who had a past history of more than one cervicotomy.
CONCLUSION: The frequency of bilateral cancer justifies completing thyroidectomy after partial thyroidectomy. The rate of definitive complications after re-operations is greater than first line cervicotomy but is low enough to allow iterative surgery using rigorous procedure in selected patients.

Entities:  

Mesh:

Year:  1997        PMID: 9569907

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  1 in total

1.  Analysis of the factors that have an effect on hypocalcemia following thyroidectomy.

Authors:  Doğa Kalyoncu; Doğan Gönüllü; Mehmet Lari Gedik; Muzaffer Er; Erol Kuroğlu; Ayşenur A İğdem; Ferda Nihat Koksoy
Journal:  Ulus Cerrahi Derg       Date:  2013-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.